Metraipolis › archive › dc_a016d50bdc83

Durvalumab consolidation therapy in patients with stage III small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis — Europe PMC PMID:41267974

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41267974
DOI
10.3389/fonc.2025.1643022
License (as archived)
solo-consultazione
Archived
2026-11-08T18:39:54.208Z
SHA-256 of the archived text
991ca8b893db9dd837f8226758af2725872649631d2d271a7137de21b17bf0cc
Stable URL of this page
https://metraipolis.com/documento/dc_a016d50bdc83

How to cite

Durvalumab consolidation therapy in patients with stage III small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis — Europe PMC PMID:41267974 — Europe PMC (en), https://europepmc.org/article/MED/41267974 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a016d50bdc83 (Metraipolis archive dc_a016d50bdc83, sha256 991ca8b893db9dd837f8226758af2725872649631d2d271a7137de21b17bf0cc)
BibTeX
@misc{dca016d50bdc83,
  title = {Durvalumab consolidation therapy in patients with stage III small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis — Europe PMC PMID:41267974},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41267974},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a016d50bdc83; sha256 991ca8b893db9dd837f8226758af2725872649631d2d271a7137de21b17bf0cc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41267974. Agents can read the archived copy with the MCP tool read_document.